Cardiovascular Health

JUPITER: Separating the Solid Clinical Matter From the Hot Gas

By August West | Contributing Writer - Vol. 9, No. 4. , 2008

Gaseous Surface of Jupiter: Many cardiologists are hailing the massive JUPITER trial as a breakthrough, claiming that statin therapy could reduce cardiovascular risk even in patients with normal LDL.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

IDA Medical Foundation Seeks to “Democratize” Prevention

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. , 2008

Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. , 2008

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

“NO” News is Good News: Nitric Oxide for CVD & Diabetes

By Tamara Sofi-Smith, PhD candidate | Contributing Writer - Vol. 9, No. 4. , 2008

“From diabetes to hypertension, cancer to drug addiction, stroke to intestinal motility, memory and learning disorders to septic shock, sunburn to anorexia, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role.”

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Chronic Fatigue, Cardiomyopathy & Oxidative Stress: New Thinking Opens New Approaches

By Allison Templet | Contributing Writer - Vol. 9, No. 3. , 2008

Chronic fatigue syndrome (CFS), one of the most vexing conditions for patients and doctors alike, reflects a state of oxygen toxicity, and management of oxidative stress appears to be a key to reversing the fatigue, pain, and neuropsychological complaints associated with this disorder, says Paul R. Cheney, MD, PhD, a pioneer in the clinical research of CFS.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Metabolic Cardiology: Solving the Heart’s Energy Crisis

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 2. , 2008

A new vanguard of “metabolic” cardiologists contends that cholesterol elevation has been overstated as a cause of heart disease, and that physicians should pay more attention to the heart muscle itself. A quartet of nutrients magnesium, co-enzyme Q10, L-carnitine, and D-ribose can profoundly improve the heart’s pumping ability and reduce risk of death, even in very ill patients.

HPC Readers Boost TACT Trial Enrollment

By Staff Writer - Vol. 9, No. 2. , 2008

Readers of Holistic Primary Care are giving a big boost to the Trial to Assess Chelation Therapy (TACT), a landmark NIH study to determine whether chelation therapy can prevent heart attacks. After reading about the ongoing trial in our Spring 2008 edition, 17 physician readers called the study’s headquarters in Miami Beach, seeking to enroll their clinics as study sites.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

D, C and CVD: New Studies Correlate Deficiencies With Cardiovascular Risk

By August West | Contributing Writer - Vol. 9, No. 1. , 2008

Two new studies provide fresh data showing that deficiencies in vitamin D and vitamin C are strongly associated with increased risk of myocardial infarction and stroke. The big-and still unanswered question—is whether supplementing with these vitamins will reduce that risk.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

“Bad Cholesterol”: Good Marketing, But Is It Good Medicine?

By Cleaves M. Bennett, MD | Contributing Writer - Vol. 8, No. 3. , 2007

The cholesterol model of heart disease, which labels LDL as “bad” and HDL as “good,” has certainly helped drug companies sell a lot of statin medications. But has it really reduced the impact of obesity, heart disease and diabetes in this country? “Not really,” says Dr. Cleaves Bennett, one of the nation’s leading experts on hypertension, kidney disease and preventive medicine.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Does C-reactive Protein Have a Place in the CVD Risk Pantheon?

By Michael Traub, ND - Vol. 8, No. 1. , 2007

One of the hottest debates in cardiology for the past few years centers on the question of whether C-reactive protein is a meaningful risk indicator for heart disease. It clearly correlates with a tendency toward inflammation, but is it truly causative? Dr. Traub contends that even if there’s no direct causal relationship, an elevated CRP is telling you that something’s wrong—something that warrants attention.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.